BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 11820177)

  • 1. [Prevention and therapy of infections in tumor patients].
    Burgmann H
    Wien Med Wochenschr; 2001; 151(24):600-14. PubMed ID: 11820177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Why empirical therapy?
    Klastersky J
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i14-5. PubMed ID: 19372173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Infections in immunosuppressed children].
    Wiger K; Høiby EA; Wathne KO
    Tidsskr Nor Laegeforen; 2005 May; 125(9):1168-72. PubMed ID: 15880153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Diagnostic procedures and management of Fever in pediatric cancer patients].
    Laws HJ; Ammann RA; Lehrnbecher T
    Klin Padiatr; 2005 Nov; 217 Suppl 1():S9-16. PubMed ID: 16288350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group.
    Tamura K
    Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prophylaxis of infection in neutropenic patients. Guidelines of the Working Party on Infections in Hematology and Oncology].
    Kern WV; Beyer J; Böhme A; Buchheidt D; Cornely O; Einsele H; Kisro J; Krüger W; Maschmeyer G; Ruhnke M; Schmidt CA; Schwartz S; Szelenyi H;
    Dtsch Med Wochenschr; 2000 Dec; 125(51-52):1582-8. PubMed ID: 11199452
    [No Abstract]   [Full Text] [Related]  

  • 7. [Changes in the epidemiology of infections in patients with febrile neutropenia].
    Karthaus M; Carratala J
    Wien Med Wochenschr; 2001; 151(3-4):47-52. PubMed ID: 11789419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Summary and comments.
    Sinkó J; Kullberg BJ; Edwards JE; Anaissie E
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i41-3. PubMed ID: 19372182
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prevention of mycotic infections in oncology patients with regard to the toxicity of antimycotic agents].
    Doubek M; Mayer J; Horký D; Doubek J; Rácil Z; Vorlícek J
    Vnitr Lek; 2002 Mar; 48(3):248-54. PubMed ID: 11968587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial chemoprophylaxis in immunocompromised patients.
    Frøland SS
    Scand J Infect Dis Suppl; 1990; 70():130-40. PubMed ID: 2287895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antimicrobial prophylaxis and therapy in neutropenia].
    Link H
    Mycoses; 2003; 46 Suppl 2():21-32. PubMed ID: 15055140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic prophylaxis in chemotherapy-induced neutropenia: time to reconsider.
    Lo N; Cullen M
    Hematol Oncol; 2006 Sep; 24(3):120-5. PubMed ID: 16783844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Critical appraisal of antimicrobials for prevention of infections in immunocompromised hosts.
    Hathorn JW
    Hematol Oncol Clin North Am; 1993 Oct; 7(5):1051-99. PubMed ID: 8226565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention of infections in immune deficiency].
    Lange B; Neumann S; Hirsch HH; Kern WV
    Dtsch Med Wochenschr; 2014 Oct; 139(40):1999-2002. PubMed ID: 25254394
    [No Abstract]   [Full Text] [Related]  

  • 15. [Antibiotics and antimycotics in oncology].
    Krcméry V
    Vnitr Lek; 1991; 37(7-8):695-702. PubMed ID: 1755212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The changing face of febrile neutropenia-from monotherapy to moulds to mucositis. Fever and neutropenia: the early years.
    Bodey GP
    J Antimicrob Chemother; 2009 May; 63 Suppl 1():i3-13. PubMed ID: 19372179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial prophylaxis in febrile neutropenia.
    Yoshida M; Ohno R
    Clin Infect Dis; 2004 Jul; 39 Suppl 1():S65-7. PubMed ID: 15250025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prevention, diagnosis and therapy of infections in patients with malignant diseases].
    Hiddemann W; Maschmeyer G; Runde V; Einsele H
    Internist (Berl); 1996 Dec; 37(12):1212-24. PubMed ID: 9081922
    [No Abstract]   [Full Text] [Related]  

  • 19. [Therapy of bacterial infections in neutropenic and immunocompromised patients].
    Helbig W; Tauchnitz R
    Z Gesamte Inn Med; 1992 Sep; 47(9):417-21. PubMed ID: 1441670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectious complications of acute and chronic GVHD.
    Young JA
    Best Pract Res Clin Haematol; 2008 Jun; 21(2):343-56. PubMed ID: 18503997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.